Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02506842
What this trial is testing

Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

Who this might be right for
Stage ⅠA Pancreatic CancerStage ⅠB Pancreatic CancerStage ⅡA Pancreatic Cancer+1 more
Fudan University 300
Testing effectiveness (Phase 2)Ended earlyNCT03457142
What this trial is testing

Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Roswell Park Cancer Institute 15
Early research (Phase 1)Study completedNCT00357305
What this trial is testing

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Looking for participantsNCT07283822
What this trial is testing

Amping up With PemJAK

Who this might be right for
Non-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+5 more
Seda S. Tolu 53
Not applicableStudy completedNCT00179231
What this trial is testing

Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Vanderbilt University 80
Testing effectiveness (Phase 2)WithdrawnNCT00242931
What this trial is testing

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Not applicableActive Not RecruitingNCT04142372
What this trial is testing

Tissue Microarray of Hematological Malignancies

Who this might be right for
Hematological Malignancies
Tampere University Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Testing effectiveness (Phase 2)UnknownNCT05059912
What this trial is testing

CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma

Who this might be right for
Refractory and Relapsed T Cell Lymphoma
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT00003400
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 45
Early research (Phase 1)Looking for participantsNCT06732492
What this trial is testing

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Who this might be right for
NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Testing effectiveness (Phase 2)Ended earlyNCT02663271
What this trial is testing

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastomaMalignant Glioma+1 more
University of Florida 10
Testing effectiveness (Phase 2)Looking for participantsNCT04544592
What this trial is testing

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin Lymphoma
University of Colorado, Denver 45
Very early researchUnknownNCT05979792
What this trial is testing

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Zhao Weili 35
Testing effectiveness (Phase 2)UnknownNCT04745975
What this trial is testing

Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Fudan University 100
Early research (Phase 1)Study completedNCT00287937
What this trial is testing

Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT01774253
What this trial is testing

Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma

Who this might be right for
Pontine Glioma
Giselle Sholler 9
Testing effectiveness (Phase 2)UnknownNCT03805399
What this trial is testing

FUSCC Refractory TNBC Umbrella (FUTURE)

Who this might be right for
Triple-negative Breast Cancer
Fudan University 140
Large-scale testing (Phase 3)Study completedNCT00436631
What this trial is testing

Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy

Who this might be right for
Epilepsy
Johns Hopkins University 30
Early research (Phase 1)Looking for participantsNCT06158139
What this trial is testing

Autologous CAR-T Cells Targeting B7-H3 in PDAC

Who this might be right for
Pancreas CancerRelapseResistant Cancer
UNC Lineberger Comprehensive Cancer Center 27
Next Page